Research progress on sarcopenia in the musculoskeletal system
Open accessThe DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Abstract
Sarcopenia, a progressive and systemic skeletal muscle disorder marked by the accelerated deterioration of both muscle function and mass, is highly prevalent among the elderly population, significantly contributing to an elevated risk of adverse outcomes, including falls, fractures, and muscle weakness. Clinical investigations have identified a strong correlation between sarcopenia and several prevalent degenerative skeletal muscle disorders. This correlation is attributed to imbalances in joint mechanics resulting from localized muscle atrophy and the influence of musculoskeletal secretory factors. In this review, we discuss the broader implications of sarcopenia and critically evaluate the currently established assessment methods. Furthermore, the clinical significance of prevalent musculoskeletal disorders (including osteoporosis, osteoarthritis, and spinal pathologies) in relation to sarcopenia, alongside the underlying mechanisms influencing this relationship, is summarized. Additionally, the effects of sarcopenia on the therapeutic efficacy of medications and surgical interventions for musculoskeletal conditions are reviewed. Sarcopenia is intricately linked to the onset, progression, and prognosis of musculoskeletal disorders. Future research should prioritize elucidating the potential mechanisms that connect muscle loss with skeletal muscle diseases, and investigating whether mitigating sarcopenia symptoms could decelerate the progression of these disorders, thereby paving new pathways for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Studies utilizing dual-energy X-ray absorptiometry (DEXA) and physical performance tests—such as the Short Physical Performance Battery (SPPB) and handgrip strength assessments—have documented declines in functional status in a subset of patients receiving GLP-1 RAs, particularly in those who do not engage in concurrent physical activity interventions [57].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [57]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These effects appear to be mediated, at least in part, by reductions in systemic and local low-grade inflammation and improvements in metabolic and mitochondrial efficiency [56,57,58].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 2×
“75 Screening methods for sarcopenia within community settings must be simple, rapid, and user-friendly.”
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867 · cited 2×
“185 Emerging evidence suggests that select anabolic agents, including myostatin inhibitors, can simultaneously enhance muscle and bone mass. 186 Notably, the soluble activin type IIB receptor (ActRIIB-Fc) demonstrated signi fi cant ef fi cacy in a murine muscular atrophy model, increasing both…”
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070 · cited 4×
“1,20 – 22 Additionally, we evaluated the strengths and limitations of these commonly used methods (Table 1).”
InfluentialSarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 1×
“1,57 Due to these advantages, BIA is increasingly being considered a practical alternative to dual-energy X-ray absorptiometry (DEXA).”
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905 · cited 1×
“10 In addition, Insulin resistance secondary to metabolic dysregulation (e.g., diabetes and dyslipidemia) compromises skeletal muscle glucose metabolism while enhancing ectopic lipid deposition through increased cellular uptake of triglycerides and free fatty acids.”
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Roberts, H. C., Denison, H. J., Martin, H. J., Patel, H. P., Syddall, H., Cooper, C., & Sayer, A. A. (2011) · Age and Ageing · doi:10.1093/ageing/afr051 · Cited by 3,001 · cited 1×
“23 This evaluation requires participants to rise from a seated position in a chair and return to a seated posture without using their arms to assist.”
A 30-s chair-stand test as a measure of lower body strength in community-residing older adults.
Jones, C. J., Rikli, R. E., & Beam, W. C. (1999) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1999.10608028 · Cited by 2,921
Research works printed but not linked: 1
- Binotto, M. A., Lenardt, M. H. & Rodríguez-Martínez, M. D. C. Physical frailty and gait speed in community elderly: a systematic review. Rev. da Esc. de. Enferm. da U S P 52, e03392 (2018).
Cited by
Araújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 40
“…Working Group on Sarcopenia in Older People 2 (EWGSOP2) study, as a muscle disorder characterized by progressive and generalized loss of the quality and quantity of skeletal muscle structure [1], resulting in adverse events such as difficulty in locomotion [2] and, in extreme cases, mortality [3].”
Moscucci, F., Baratta, F., Pastori, D., Menichelli, D., Mattioli, A. V., Gallina, S., Lospinuso, I., Sciomer, S., Piccirillo, G., & Desideri, G. (2026) · Nutrients · doi:10.3390/nu18040632 · Cited by 11
“…physical performance tests—such as the Short Physical Performance Battery (SPPB) and handgrip strength assessments—have documented declines in functional status in a subset of patients receiving GLP-1 RAs, particularly in those who do not engage in concurrent physical activity interventions [57].”
Zhang, X., Wang, Z., Wang, J., Wu, F., Xia, L., Shi, S., Zhu, M., & Zhuang, J. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s560139 · Cited by 6
“46 However, due to various limitations, they are not typically used as routine bedside tools.”
Skeletal Fiber Type in Muscle Pain and Dysfunction
Cardia, M. L., Carneiro, B. D., Tavares, I., & Pozza, D. H. (2026) · Biomedicines · doi:10.3390/biomedicines14040794 · Cited by 2
“…in Type II fibers, associated satellite cell pools, and progressive intramuscular fat infiltration, changes that are further exacerbated by systemic metabolic dysregulation, particularly insulin resistance, which promotes ectopic lipid accumulation and impaired muscle glucose metabolism [72–74].”
Azim, M. M. N., Lee, Y. K., Alam, M. J., Kim, J., & Park, J. H. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119441 · Cited by 7
Metadata
- Authors
- Mao, X., Lv, K., Qi, W., Cheng, W., Li, T., Sun, Y., Jin, H., Pan, H., & Wang, D.
- Affiliations
- Zhejiang Chinese Medical University (CN)
- Corresponding author
- Jin, Hongting
- Pan, Hao
- Wang, Dong
- Venue
- Bone Research
- Published
- 2025-09-23
- Volume
- 13
- Issue
- 1
- Pages
- 78-78
- ISSN
- 2095-4700 (ISSN-L)
- 2095-6231
- PMC
- PMC12457612
- OpenAlex
- W4414418007
- Cited by
- 37
- References
- 244
- Citations by year
- 2026: 34 · 2025: 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Bone Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82405429)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- sarcopenia, skeletal muscle atrophy, musculoskeletal disorders, osteoporosis, osteoarthritis, spinal pathology, falls and fractures, muscle weakness, joint mechanics, sarcopenia assessment
- MeSH terms
- Humans, Musculoskeletal Diseases, Musculoskeletal System, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research progress on sarcopenia in the musculoskeletal system. https://app.cochat.ai/papers/10.1038/s41413-025-00455-8
- The paper
- Mao, X., Lv, K., Qi, W., Cheng, W., Li, T., Sun, Y., Jin, H., Pan, H., & Wang, D. (2025). Research progress on sarcopenia in the musculoskeletal system. Bone Research. https://doi.org/10.1038/s41413-025-00455-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.